Transitional cell carcinoma of the bladder following augmentation cystoplasty for the neuropathic bladder.
about
Augmentation cystoplasty in neurogenic bladderIncreased cancer risk of augmentation cystoplasty: possible role for hyperosmolal microenvironment on DNA damage recognitionMinced skin for tissue engineering of epithelialized subcutaneous tunnels.Tissue engineering of rat bladder using marrow-derived mesenchymal stem cells and bladder acellular matrix.Highlights of the university of toronto urology update 2014.Presentation of case: Bladder cancer in an 18 year old female patient.In Vitro Evaluation of Spider Silk Meshes as a Potential Biomaterial for Bladder Reconstruction.Adenoma-carcinoma Sequence in the Bladder After Augmentation CystoplastyA case of tubular adenoma developing after bladder augmentation: Case report and literature reviewA Large Bladder Tumor Covered With a Thick "Shell" of Necrotic Material: Misdiagnosis of a Patient With Spina Bifida.Tissue-engineered tubular substitutions for urinary diversion in a rabbit modelAdolescent urology: A challenge for adult urologists.Bladder augmentation: Review of the literature and recent advances.Late effects on the urinary bladder in patients treated for cancer in childhood: a report from the Children's Oncology Group.Complications following breast cancer therapy in the adult spina bifida population: A case report.Is continent urinary diversion feasible in children under five years of age?Nanostructured bladder tissue replacements.Diagnosis and management of urothelial carcinoma of the bladder.Is tissue engineering and biomaterials the future for lower urinary tract dysfunction (LUTD)/pelvic organ prolapse (POP)?Malignancy after gastrointestinal augmentation in childhoodWhen urothelial differentiation pathways go wrong: implications for bladder cancer development and progression.The past, present and future of augmentation cystoplasty.The treatment of lower urinary tract symptoms in patients with multiple sclerosis: a systematic review.Renal transplantation in augmented bladders.Risk of malignancy after augmentation cystoplasty: A systematic review.Augmentation cystoplasty: Urodynamic and metabolic outcomes at 10-year follow-up.Research Needs for Effective Transition in Lifelong Care of Congenital Genitourinary Conditions: A Workshop Sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases.Augmentation cystoplasty: Contemporary indications, techniques and complications.Preperitoneal Bladder Augmentation: Feasibility and Results.Surface modification of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) copolymer films for promoting interaction with bladder urothelial cells.Inflammatory microenvironment in the initiation and progression of bladder cancer.Transition to adulthood with a bladder augmentation: histopathologic concerns.Molecular characteristics of urothelial neoplasms in children and young adults: a subset of tumors from young patients harbors chromosomal abnormalities but not FGFR3 or TP53 gene mutations.
P2860
Q28077456-43486BEF-53BE-4AF4-B30E-7C1195FCC5F5Q33489163-39B53DC7-75CE-4342-89E4-75DB7C9899EFQ33609057-759DECEA-5335-4603-9D8E-D40D731C0DCCQ34599502-C2A321BB-CD6D-4C36-9754-8C92BED18220Q35100023-84336DC7-B5DB-4816-BD29-A31BBBFEEF5FQ35142058-6DDC7E66-93E9-4093-9CC7-70CC4F1FDE2CQ35874141-E0223202-AEA1-4A28-96D1-BCD28F4A1F7DQ36520796-75C73888-96D0-4BDD-B06A-F8E0F8DC9E46Q36586976-A35A7739-F7DF-4101-B4A9-E481D7C3AFE8Q36838105-602C9FB6-F5DE-478D-9BDD-A8CB1DC64B99Q37071490-92CD3D44-D0EB-45F5-848B-B3AF4C29515CQ37291113-C6EB9452-7EAF-4614-AD7F-7645BF340B63Q37291164-E9CABAE7-0E99-45AA-9F43-379F090AD4FDQ37318045-B808D172-27A9-49DD-9855-865F9F21E4F9Q37342912-2F8D0232-649D-4028-A8F2-E3F5DBEC2FD8Q37589753-7F3FABB8-6250-43D1-9F12-5C85C0371ED5Q37781773-2DE5D56D-C590-4073-A3F3-AD03C51EB583Q37874887-CD913BE0-E692-4968-A153-D278F4BFEA6BQ37887670-FDF5E7BF-CCCF-43FA-9428-609201550837Q37905550-40B28E45-B4DE-4BCB-BBA7-D58396F700A7Q37933675-E777DC15-68AB-4BC3-8453-E5EADB621960Q37960982-7C48D21D-DFF9-4177-AAA5-BCAD3AB6CEC8Q38034119-092DDDE5-8DB9-4BAA-8A1B-2DA394D4F222Q38219270-046270DA-3A11-44D7-8923-237256E30CCAQ38418109-F6CA4028-3E54-477F-A356-ACA4926A06C2Q38590601-A6867773-4ECC-45C7-A9F1-7A224AD16E0EQ39120513-8DD0CB11-3E36-4CCC-8836-02D6E3E3B455Q39314841-A1F0C5C2-6B52-406F-AADB-7CB6DA9A0D97Q41872119-6E88DEC8-BCF7-47E3-ADBD-387312FF0B9FQ44700524-7203B39F-4661-4C3B-8CDE-B3D79CF1C4C4Q46779353-FB7B7B0B-3A54-489E-9B0D-F8CF44044CA5Q47136584-81F92BBF-DB32-4E6D-ACCB-70A1218B573BQ53239118-B0FF812D-698B-46DB-A189-E4382C44A079
P2860
Transitional cell carcinoma of the bladder following augmentation cystoplasty for the neuropathic bladder.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Transitional cell carcinoma of ...... y for the neuropathic bladder.
@ast
Transitional cell carcinoma of ...... y for the neuropathic bladder.
@en
type
label
Transitional cell carcinoma of ...... y for the neuropathic bladder.
@ast
Transitional cell carcinoma of ...... y for the neuropathic bladder.
@en
prefLabel
Transitional cell carcinoma of ...... y for the neuropathic bladder.
@ast
Transitional cell carcinoma of ...... y for the neuropathic bladder.
@en
P2093
P1476
Transitional cell carcinoma of ...... y for the neuropathic bladder.
@en
P2093
Mark P Cain
Michael O Koch
Richard C Rink
Thomas A Gardner
Trevor M Soergel
P304
1649-51; discussion 1651-2
P356
10.1097/01.JU.0000140194.87974.56
P407
P433
P577
2004-10-01T00:00:00Z